ATE320445T1 - Ein hausmilbeallergen (der p iii), dessen anwendung und dafür kodierte nukleinsäuren - Google Patents

Ein hausmilbeallergen (der p iii), dessen anwendung und dafür kodierte nukleinsäuren

Info

Publication number
ATE320445T1
ATE320445T1 AT95904273T AT95904273T ATE320445T1 AT E320445 T1 ATE320445 T1 AT E320445T1 AT 95904273 T AT95904273 T AT 95904273T AT 95904273 T AT95904273 T AT 95904273T AT E320445 T1 ATE320445 T1 AT E320445T1
Authority
AT
Austria
Prior art keywords
iii
der
nucleic acids
allergen
mile
Prior art date
Application number
AT95904273T
Other languages
English (en)
Inventor
Wayne R Thomas
Kaw-Yan Chua
Bruce L Rogers
Mei-Chang Kuo
Original Assignee
Immulogic Pharma Corp
Inst Child Health Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharma Corp, Inst Child Health Res filed Critical Immulogic Pharma Corp
Application granted granted Critical
Publication of ATE320445T1 publication Critical patent/ATE320445T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Building Environments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95904273T 1993-12-08 1994-12-07 Ein hausmilbeallergen (der p iii), dessen anwendung und dafür kodierte nukleinsäuren ATE320445T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/163,919 US6180771B1 (en) 1993-12-08 1993-12-08 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor

Publications (1)

Publication Number Publication Date
ATE320445T1 true ATE320445T1 (de) 2006-04-15

Family

ID=22592177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95904273T ATE320445T1 (de) 1993-12-08 1994-12-07 Ein hausmilbeallergen (der p iii), dessen anwendung und dafür kodierte nukleinsäuren

Country Status (12)

Country Link
US (5) US6180771B1 (de)
EP (1) EP0733064B1 (de)
JP (1) JPH09510083A (de)
KR (1) KR20040004481A (de)
AT (1) ATE320445T1 (de)
AU (1) AU697491B2 (de)
CA (1) CA2177612C (de)
DE (1) DE69434665T2 (de)
ES (1) ES2260760T3 (de)
NO (1) NO317850B1 (de)
NZ (1) NZ277698A (de)
WO (1) WO1995015976A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180771B1 (en) * 1993-12-08 2001-01-30 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
MXPA01005389A (es) * 1998-11-30 2003-03-27 Cytos Biotechnology Ag Presentacion molecular ordenada de antigenos, metodos de preparacion y uso.
US7439233B1 (en) * 1999-02-25 2008-10-21 Tai June Yoo Vaccine for house dust mite allergen using naked DNA
EP1133994A1 (de) * 2000-03-11 2001-09-19 Biognostik Gesellschaft für biomolekulare Diagnostik mbH Verfahren zür Umwandlung des immunosuppresive effekts von MIA (Melanoma Inhibitory Activity)
EP2338510A1 (de) * 2002-07-19 2011-06-29 Novartis Pharma AG Impfstoffzusammensetzungen, die Amyloid-beta1-6 Antigen-Arrays enthalten
WO2004078965A1 (ja) * 2003-03-05 2004-09-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 大腸菌における異種蛋白質の製造方法
GB0424563D0 (en) * 2004-11-05 2004-12-08 Novartis Ag Organic compounds
NZ583362A (en) * 2007-08-15 2012-06-29 Circassia Ltd Peptide with reduced dimer formation
KR101420064B1 (ko) * 2013-12-31 2014-07-15 경북대학교 산학협력단 Panonychus 속 진단용 종-특이적 프라이머 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338663A (en) * 1990-08-24 1994-08-16 President And Fellows Of Harvard College Method of identifying inhibitors of β-protein esterase activity
US5506097A (en) * 1990-08-24 1996-04-09 President And Fellows Of Harvard College Method for inhibiting β-protein enzymatic activity
JP3139777B2 (ja) * 1990-08-27 2001-03-05 フマキラー株式会社 組換えダニアレルゲン
DE69233772D1 (de) 1991-10-16 2009-11-12 Merck Patent Gmbh T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
US5710126A (en) * 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US6180771B1 (en) 1993-12-08 2001-01-30 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
US20040092446A1 (en) * 1997-07-23 2004-05-13 Goulmy Elsa A.J.M. HA-1 epitopes and uses thereof

Also Published As

Publication number Publication date
NO962407L (no) 1996-06-07
US20050123569A1 (en) 2005-06-09
JPH09510083A (ja) 1997-10-14
US9447154B2 (en) 2016-09-20
EP0733064A1 (de) 1996-09-25
NO962407D0 (no) 1996-06-07
KR20040004481A (ko) 2004-01-13
US6180771B1 (en) 2001-01-30
US20110117116A1 (en) 2011-05-19
NZ277698A (en) 1998-04-27
AU697491B2 (en) 1998-10-08
US20110059522A1 (en) 2011-03-10
AU1302795A (en) 1995-06-27
ES2260760T3 (es) 2006-11-01
US7666429B2 (en) 2010-02-23
US8287875B2 (en) 2012-10-16
US6752991B1 (en) 2004-06-22
NO317850B1 (no) 2004-12-20
CA2177612C (en) 2010-02-16
EP0733064B1 (de) 2006-03-15
CA2177612A1 (en) 1995-06-15
DE69434665T2 (de) 2007-02-08
DE69434665D1 (de) 2006-05-11
WO1995015976A1 (en) 1995-06-15

Similar Documents

Publication Publication Date Title
WO1994016068A3 (en) Allergenic proteins and peptides from dog dander and uses therefor
EP1018550A3 (de) Allergene Proteine und Peptide aus Hausstaubmilben und deren Verwendungen
FI941757A0 (fi) Dermatofagoideista (talopölypunkki) peräisin olevien pääallergeenien T-soluepitoopit
NZ256255A (en) Protein allergen of der p ii, and pharmaceutical compositions containing them
WO2004089280A3 (en) Reversible pegylated drugs
SE8703938L (sv) Peptidderivat
ATE320445T1 (de) Ein hausmilbeallergen (der p iii), dessen anwendung und dafür kodierte nukleinsäuren
DE09004306T1 (de) Mit Copolymer 1 verwandte Polypeptide zur Verwendung als Molekulargewichtsmarker und zur therapeutischen Verwendung
ATE87006T1 (de) Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung.
Schuppan et al. Covalent Structure of Mouse Type‐IV Collagen: Isolation, Order and Partial Amino‐Acid Sequence of Cyanogen‐Bromide and Tryptic Peptides of Pepsin Fragment P1 from the αl (IV) Chain
HUP0003563A2 (hu) Aminoterminálisa felől csonkolt MCP-2 mint kemokinantagonista
EP0187721A3 (de) Herstellung von Peptidsubstraten für virus-spezifierte Proteasen
Brankamp et al. Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-related inhibitors
EP0486520B1 (de) Für kappa-opioid-rezeptoren spezifische dynorphinanaloga
JPS6087299A (ja) ナチユラルキラ−細胞活性増大用ペプチド
US20030064021A1 (en) Neutrophil stimulating peptides
Bongers et al. Capillary zone electrophoresis of degradative and cyclic lactam derivatives of the growth hormone-releasing factor peptide
Buczko et al. Biological effects of degradation products of collagen by bacterial collagenase
CA2121497A1 (en) T cell epitopes of the major allergens from dermatophagoides (house dust mite)
Henschen Genetically Abnormal Human Fibrinogens—a Summary of 32 Structurally Elucidated Variants
ES2051152B1 (es) Procedimiento de sistesis de peptidos con capacidad de detectar anticuerpos anti-virus de la hepatitis c (vhc) en suero de individuos afectados.
Kubiak et al. Probing SAR of FLRF-NH2 with its N-and C-terminally modified analogs and retro-inverso peptides

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0733064

Country of ref document: EP